Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation

https://doi.org/10.1016/0002-9149(93)91136-6Get rights and content

Abstract

Clinical records, electrocardiographic, echocardiographic, hemodynamic and radionuclide data, and the operatively excised hearts were reviewed in 10 patients (aged 19 to 46 years, mean 35) who had cardiac transplantation for hypertrophic cardiomyopathy. Severe congestive heat failure unassociated with outflow obstruction was the indication for transplantation in 9 patients. During a pretransplantation period ringing from 45 to 312 months (mean 137) in these 9 patients, pulmonary artery wedge pressure increased from 19 ± 9 to 27 ± 7 mm Hg, left ventricular ejection fraction decreased from 51 ± 11% to 41 ± 1%, left ventricular end-diastolic dimension increased from 42 ± 6 to 48 ± 4 mm, and total 12-lead QRS voltage decreased from 209 ± 50 to 156 ± 41 mm. In these 9 patients, the explanted hearts had dilated left ventricular cavities, and 8 had left ventricular scars without significant narrowing of the epicardial coronary arteries. The tenth patient had a nondilated left ventricular cavity and had transplantation because of recurrent, refractory syncope. Of the 10 patients, 3 died within the first month, and another died 8 months after transplantation. The remaining 6 patients have survived 20 to 54 months (mean 39) after transplantation and are in functional class I or II.

Cited by (65)

  • Relationship between measures of left ventricular systolic and diastolic dysfunction and clinical and biomarker status in patients with hypertrophic cardiomyopathy

    2022, Archives of Cardiovascular Diseases
    Citation Excerpt :

    In HCM, beside patients with end-stage heart failure, a subset of candidates with refractory heart failure, mainly as a result of severe diastolic dysfunction despite preserved ejection fraction, should be evaluated for transplantation when no other therapeutic options are reasonable. Restrictive filling pattern both at baseline evaluation and during the follow-up period is an independent predictor of death or the need for heart transplantation in HCM [95]. This point underscores the importance of longitudinal follow-up in patients with non-obstructive HCM, and the need for general cardiologists, unfamiliar with cardiomyopathy management, to refer patients to tertiary centres to ensure optimal treatment strategies.

  • Hypertrophic cardiomyopathy with a complex clinical course leading to heart transplantatioN

    2022, Cardiovascular Pathology
    Citation Excerpt :

    Both the cases had a similar indication for heart transplantation—progressive heart failure and D-HCM. Severe congestive heart failure, unassociated with outflow obstruction, is the most frequent indication for transplantation in most HCM patients [19]. In case 1, severe primary graft dysfunction required a redo-transplant.

  • Usefulness of Total 12-Lead QRS Voltage for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy in Patients With Heart Failure Severe Enough to Warrant Orthotopic Heart Transplantation and Morphologic Illustration of Its Cardiac Diversity

    2018, American Journal of Cardiology
    Citation Excerpt :

    Described herein are findings from measurement of total 12-lead QRS voltage and findings from the examination of the native hearts in 11 patients who underwent OHT because of severe heart failure due to ARVC. These total 12-lead nonpaced QRS voltages (mean 74 ± 32) and paced (mean 62 ± 32) are the lowest found in any of the 12 previously reported conditions we have studied (summarized in Table 3).14–26 The total 12-lead QRS voltage was lower in the 7 paced electrocardiograms than in the 6 nonpaced electrocardiograms.

View all citing articles on Scopus

Division of Cardiology, Department of Medicine, Medical College of Virginia, Richmond, Virginia 23298.

Cardiovascular Research Division, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407.

View full text